In the dynamic realm of pharmaceuticals, market access strategy wields immense influence over a brand’s destiny. Imagine a groundbreaking treatment—innovative, potent—but if it remains uncovered or unreimbursed, its potential impact on patients remains unrealized. Market access is the gateway that decides whether a brand thrives or languishes. But that’s if market access strategy and stakeholder engagement is done right. Unfortunately, that’s still not standard across the industry. In this POV, we dissect three critical market access pitfalls and how modern brands can avoid th ..read more

As medical affairs within pharmaceutical companies continues to adopt omnichannel solutions, it must meet a growing volume of content demands. Modular content strategy presents a disciplined and structured solution for creating medical assets by utilizing preapproved content blocks, or “modules.”   A module is a combination of individual content elements (e.g., scientific statements, infographics, headlines, charts, copy) that tell a complete story within a particular topic or message. Because modules are stand-alone, channel-agnostic blocks of scientific and medical content, they ca ..read more

Leveraging cause marketing and empathy in a world of doubt In a world inundated with manipulated images and misinformation, trust is becoming an increasingly scarce and precious commodity. The recent royal photo fiasco surrounding Princess Kate serves as a stark reminder of the challenges posed in the AI age, where discerning reality from fabrication is becoming more and more difficult. However, amidst this crisis of trust, there lies an opportunity for brands – especially pharmaceutical companies – to forge genuine connections with consumers through cause marketing and empathy-driven advertis ..read more

Adobe Summit is the tech behemoth’s annual conference, where the company not only showcases its capabilities and innovations, but also hosts wider discussions of how digital marketing is changing in the face of technological and societal evolution. Many summaries of the meeting and its sessions are available, but you probably want more than that. What does it all actually mean? What are the implications of these advances for life sciences marketers? To that end, the EVERSANA INTOUCH expert team who attended Adobe Summit synthesized the concepts they saw playing out and are providing their insi ..read more

Missed our SXSW coverage from the 2024 conference? Check out all the valuable insights our team on the ground curated while in Austin, TX! SXSW 2024 Insights: Why the Greatest Risk a Brand Can Take Is Being Ordinary, Part 1 In this blog, Hattie Stearns, Senior Director of Experience DesignOps, delves into several key trends and insights from Day 1 of the conference, including the importance of building authentic immersive experiences that enable human connection, how the best brands create communities, and why the greatest risk a brand can take is being ordinary. The New Authenticity: SX ..read more

At SXSW 2024, amidst a confluence of marketing, technology, AI, and design, one word seemed to echo through every conversation, panel, and workshop: authenticity. It’s fascinating, isn’t it? The idea of being genuine, real, and true — qualities so deeply sought after in everything we do, yet so complex and rich when we pause to unpack them. Among the minds at EVERSANA INTOUCH, with leaders spanning the spectrum from Strategic Planning to Creative Direction, and from Experience Design to Customer Experience Strategy, there emerged a dialogue. This wasn’t about authenticity as a mere buzzword bu ..read more

Healthware will operate as the agency network’s sixth full-service affiliate, EVERSANA INTOUCH Healthware, serving clients from offices worldwide  Fulvio Fortini, Senior Vice President and Managing Director, appointed as head of affiliate   Healthware founder Roberto Ascione assumes new role leading Health Innovation initiatives across EVERSANA  CHICAGO & SALERNO, Italy – 15 April 2024 – EVERSANA, a leading provider of global commercial services to the life sciences industry, today unveiled a new full-service affiliate in its EVERSANA INTOUCH global agency network, EV ..read more

The pharmaceutical industry is no stranger to innovation. It has continually evolved, embracing new technologies and methodologies to improve drug discovery, development, and distribution. In recent years, the integration of Artificial Intelligence (AI) into the pharma landscape has been nothing short of transformative, with the industry testing and implementing AI in a few key areas: Drug Discovery: Improved initial assessment of drug compounds, predicting their success rates based on biological factors and advanced next-generation sequencing. Pre-Clinical: Deeper comprehension of the impacts ..read more

In the dynamic realm where technology meets humanity, digital humans emerge as catalysts for a healthier future. With endless opportunities for innovation and advancement, these AI-driven entities are reshaping education, research and training in the life sciences industry.   What are digital humans?  Also known as digital twins or synthetic clones, digital humans blend cutting-edge innovation with human-like charm, surpassing traditional avatars or chatbots by emulating human behavior, expressions and emotions. Their presence offers transformative benefits across various domain ..read more

MM+M recently named Teva Pharmaceuticals’ AUSTEDO XR campaign as their Campaign of the Week! AUSTEDO XR helps treat tardive dyskinesia (TD), a side effect of taking medications for mental illness. It’s estimated that some 85% of TD cases go undiagnosed. To help patients and HCPs recognize TD, our team partnered with Teva on two new TV spots focusing on two different journeys of characters who have TD. In the article, Elizabeth Rooney, Executive Creative Director, EVERSANA INTOUCH, explains the strategy behind the new TV spots. “For pharma in general, it might be weeks or longer before you can ..read more